Leadership Summit will return to CPHI Milan, which runs Oct. 6-8 in Milan, Italy, as manufacturers face mounting pressu ...
The EU's pharma reform makes market protection more conditional. Here is how US drugmakers, especially startups, can adapt and use IP to complement it. The European Union's (EU) pharmaceutical reform ...
In this week's Pharma Pulse, Arkansas independent pharmacies bring an underpayment suit against Express Scripts, Novo Nordisk ...
DSCSA compliance is no longer a live question for most trading partners, but two new work streams, the shift to a 12-digit ...
As pharmaceutical companies move AI into patient access and support operations, most still rely on manual sampling and ...
Where post-launch optimization breaks down — and how to connect strategy to performance Insights from Two Labs and Riparian experts across every stage of commercialization ...
Liberty Dewey of Cardinal Health breaks down the NDC-12 transition timeline, the four work streams driving it and why the ...
Go behind the scenes of LogiPharma USA 2026 with program director Charleen Ring and McKesson's Chris Van Norman in this ...
Manufacturer market-access teams should treat affiliate “data access” charges as contract risks unless services, deliverables, and FMV methodology are explicitly defined and documented. Geographic ...
For manufacturers, wholesalers and distributors still mapping out their transition to NDC-12, the advice from Ameer Ali is straightforward: start now, and build a roadmap that accounts for how much ...
The White House said Medicaid programs in all 50 states, D.C. and Puerto Rico now receive MFN prices, with nearly $65 billion in savings over a decade. The White House announced Sept. 18 that Medicaid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results